Catalyst Wire Dossier Catalyst Wire Dossier

ATB-346

· Antibe Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ATB-346, covering 2017-07-18 to 2022-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis Patients [Phase 2]

See pricing